Embolic Stroke of Undetermined Source
📧 Sign up to get email alerts when something new happens for Embolic Stroke of Undetermined Source.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation
Clinical trial update on stroke prevention in the elderly comparing patent foramen ovale closure with anticoagulation; recruitment is ongoin…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
The SyNC trial is currently recruiting to compare high-coverage carotid stenting with medical management alone to prevent emboli in symptoma…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause [NA]
Clinical trial update: MEMO Patch is being studied for atrial fibrillation detection in patients with embolic stroke of undetermined source.…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM
An ongoing clinical trial evaluating AI-based prediction of atrial fibrillation in patients with embolic stroke of undetermined source using…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Left Atrial Strain and Cryptogenic Stroke
A University of Pittsburgh clinical trial is evaluating left atrial strain in relation to cryptogenic and other types of stroke and is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement [NA]
This is a completed study evaluating Cardea SOLO for diagnosing paroxysmal atrial fibrillation in patients with embolic stroke of undetermin…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Stroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke Recurrence
A study investigating whether long-term heart monitoring with an implantable cardiac monitor reduces recurrent stroke risk in women with cry…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Impaired Endothelial Integrity in Patients With Embolic Stroke of Undetermined Source (ESUS)
A clinical trial update from the University of Athens notes impaired endothelial integrity in patients with Embolic Stroke of Undetermined S…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
The INVISIBLE-1 trial is an ongoing study to identify newly diagnosed cancers during 1-year follow-up in patients at risk after ischemic str…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source [Phase 2, Phase 3]
A randomized Phase 2/3 trial (EMPA-ESUS) is investigating whether empagliflozin improves left atrial function in patients with embolic strok…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
An update on a clinical trial exploring paroxysmal nocturnal hemoglobinuria in embolic strokes of undetermined source (ESUS/ETUS) and relate…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt [NA]
A completed clinical trial evaluating RoBotic TCD Ultrasound Bubble studies versus transthoracic echocardiography for detecting right-to-lef…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients [Phase 4]
Open-label Phase 4 trial evaluating EZYPRO® for detecting atrial fibrillation in patients with embolic stroke of undetermined source (ESUS).
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Apixaban for Treatment of Embolic Stroke of Undetermined Source [Phase 3]
Phase 3 trial update for apixaban in the treatment of embolic stroke of undetermined source has completed.
-
CLINICAL_TRIALS research · 2019-01-30Clinical Trial Update: Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke
An observational registry study is being conducted to monitor patients with embolic stroke of undetermined source (ESUS) or cryptogenic stro…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Enhanced Detection of Underlying, Covert ATrial Fibrillation Using 7-day Holter Electrocardiogram in Patients With Embolic Stroke of Undetermined Source
The update describes a study evaluating whether 7-day Holter ECG monitoring improves detection of covert atrial fibrillation in patients wit…